Ticker Details
Sarepta Therapeutics, Inc. Sarepta Therapeutics Inc is a biotechnology company. It uses proprietary RNA-targeted technology platforms for developing pharmaceutical products to address serious diseases.
IPO Date:	July 12, 2012
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.77B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.51 | 2.48%
Avg Daily Range (30 D):	$0.51 | 2.47%
Avg Daily Range (90 D):	$0.57 | 2.84%

Institutional Daily Volume
Avg Daily Volume:	1.85M
Avg Daily Volume (30 D):	2.4M
Avg Daily Volume (90 D):	2.48M

Trade Size
Avg Trade Size (Sh.):	105
Avg Trade Size (Sh.) (30 D):	69
Avg Trade Size (Sh.) (90 D):	71

Institutional Trades
Total Institutional Trades:	14,000
Avg Institutional Trade:	$4.04M
Avg Institutional Trade (30 D):	$3.89M
Avg Institutional Trade (90 D):	$3.52M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	4

Market Closing Trades
Avg Closing Trade:	$8.73M
Avg Closing Trade (30 D):	$6.83M
Avg Closing Trade (90 D):	$6.77M
Avg Closing Volume:	129.11K

News

May 20, 2026 @ 3:15 PM My Top 3 Biotech Stocks for May 2026 Source: Jeff Siegel

May 18, 2026 @ 6:33 PM Protein Synthesis Research Market to Reach $42.8 B... Source: Bcc Research

Mar 27, 2026 @ 5:09 PM Nasdaq 100 Enters Correction As 30-Year Yields Nea... Source: Piero Cingari

Jan 26, 2026 @ 1:41 PM Stock Market Today: Dow Futures Gain, S&P 500 Slip... Source: Rishabh Mishra

Jan 22, 2026 @ 3:30 AM 2 Beaten-Down Stocks That Could Sink Even More in ... Source: Prosper Junior Bakiny

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$.73	$3.15	$-3.93
Diluted EPS	$.34	$2.88	$-3.93
Revenue	$2.18B	$730.8M	$442.93M
Gross Profit			$-29.1M
Net Income / Loss	$65.06M	$330.96M	$-412.23M
Operating Income / Loss	$-40.96M	$358.43M	$-411.58M
Cost of Revenue			$472.04M
Net Cash Flow	$221.13M	$-336.83M	$188.21M
PE Ratio

Splits
Jul 12, 2012	1:6